The Market Reports

Synopsis

The global market for Presbyopia Correction Devices was estimated to be worth US$ 37.5 million in 2024 and is forecast to a readjusted size of US$ 95.9 million by 2031 with a CAGR of 13.6% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Presbyopia Correction Devices cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Presbyopia Correction Device general has two types: corneal inlay and scleral implants. A corneal inlay (also called an intracorneal implant) is a device which is surgically implanted in the cornea of the eye as a treatment for presbyopia. Successful installation results in reducing dependence on reading glasses, so that the user can more easily engage in everyday tasks such as using a mobile phone, reading store shelf prices and working on a computer.

Corneal inlays are small, thin, and permeable. Typically one is implanted in the non-dominant eye. Scleral implants are precision-molded from a clear plastic material; the clear implants are about the size of a grain of rice and are placed just below the surface of the white of your eye (called the sclera). The only one commercially available is VisAbility™ Micro-Insert System.

As the global aging population grows, presbyopia—one of the most common age-related vision impairments—has seen a surge in corrective needs. From developed markets in North America and Europe to emerging regions like China, Southeast Asia, and the Middle East, awareness of visual quality is increasing. Consumers are shifting from conventional eyewear toward advanced surgical or device-based solutions.

The convergence of ophthalmic hospitals and aesthetic clinics is also creating new commercial channels. On the technology front, progress in accommodating IOLs, wavefront optimization, multifocal optics, and micro-invasive implantation is making devices safer, more precise, and more customizable—unleashing a new wave of product innovation.

Despite its potential, the presbyopia correction devices market faces considerable hurdles. The product development cycle is long and technologically demanding, with strict requirements on optical precision and biocompatibility. Patient acceptance and satisfaction remain variable, requiring significant investment in education and marketing. Reimbursement gaps in many countries limit accessibility for the middle class. Meanwhile, increasingly stringent regulations, such as EU MDR and US FDA standards, raise barriers for market entry and compliance. The lack of unified clinical protocols further fragments the deployment and adoption path.

Demand for presbyopia correction is shifting from purely medical interventions to lifestyle-enhancing, high-vision-quality solutions. Premium users are seeking improvements in visual comfort, nighttime clarity, and natural focusing—driving companies to refine user experience. Aging professionals such as executives, physicians, and educators are emerging as key target segments for high-margin offerings. Additionally, a new wave of smart wearable visual devices is gaining traction among early adopters. Although still in its infancy, this segment could complement or even compete with traditional device-based correction methods in the near future.

This report aims to provide a comprehensive presentation of the global market for Presbyopia Correction Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Presbyopia Correction Devices by region & country, by Type, and by Application.

The Presbyopia Correction Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Presbyopia Correction Devices.

Market Segmentation

By Company

• AcuFocus
• Revision Optics (Closed in Feb 2018)
• Refocus
• Presbia

Segment by Type

• Corneal Inlays
• Scleral Implants

Segment by Application

• Age 40-50
• Age 50-65
• Age above 65

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.